Publikationen der letzten 5 Jahre

A. Skapenko and H. Schulze-Koops. 2012. Labordiagnostik. In: Checkliste Rheumatologie, edited by B. Manger and H. Schulze-Koops. Georg Thieme Verlag, Stuttgart, 4th Edition, Chapter 2 pp 21-58, ISBN 978-3-137630043

C. Dechant and H. Schulze-Koops.2012. Synovialdiagnostik. In: Checkliste Rheumatologie, edited by B. Manger and H. Schulze-Koops. Georg Thieme Verlag, Stuttgart, 4th Edition, Chapter 3 pp 58-61, ISBN 978-3-137630043

M. Grünke and H. Schulze-Koops.2012. Rheumatoide Arthritis. In: Checkliste Rheumatologie, edited by B. Manger and H. Schulze-Koops. Georg Thieme Verlag, Stuttgart, 4th Edition, Chapter 6 pp: ISBN 978-3-137630043

A. Nigg and H. Schulze-Koops.2012. Spondyloarthropathien. In: Checkliste Rheumatologie, edited by B. Manger and H. Schulze-Koops. Georg Thieme Verlag, Stuttgart, 4th Edition, Chapter 7 pp 58-61, ISBN 978-3-137630043

M. Grünke and H. Schulze-Koops.2012. Therapie, Grundlagen. In: Checkliste Rheumatologie, edited by B. Manger and H. Schulze-Koops. Georg Thieme Verlag, Stuttgart, 4th Edition, Chapter 7 pp 58-61, ISBN 978-3-137630043

M. Grünke and H. Schulze-Koops.2012. Therapie, Medikamentöse Therapie. In: Checkliste Rheumatologie, edited by B. Manger and H. Schulze-Koops. Georg Thieme Verlag, Stuttgart, 4th Edition, Chapter 30, ISBN 978-3-137630043

A. Ramming, D. Druzd, J. Leipe, H. Schulze-Koops and A. Skapenko. 2012. Age-related histone modifications in the PU-1 promoter regulate Th9 cell development, Blood, in press

A. Nigg, H. Schulze-Koops, 2012. Rheumatoide Arthritis und Sonderformen: Klinische Immunologie, 3. Auflage und mögliche Nachdrucke (Hrsg. Peter, Pichler, Müller-Ladner):ISBN 978-3-437-23256-5

M. Czihal, X. Zanker, A. Rademacher, F. Tato, P. Kuhlencordt, H. Schulze-Koops and U. Hoffmann. 2012. Sonographic and clinical pattern of extracranial and cranialgiant cell arteritis. Scand J Rheumatol, in press

M.P. Albersmeyer, R. G. Hilge, H. Schulze-Koops and T. Sitter. 2012. Adult-onset Still’s disease in a patient with cystic fibrosis and its successful treatment with anakinra: A case report. Rheumatology, in press

B. Hoppe, T. Häupl, S. Ziemer, A. Skapenko, N.N., A. Salama, H. Schulze-Koops, H. Kiesewetter, G.R. Burmester and T. Dörner. 2012. Two-locus interactions between fibrinogen and factor XIII A-subunit influence susceptibility to rheumatoid arthritis and inversely modulate CRP levels. Ann Rheum Dis, in press

M. Rizzi, C. Neumann, AK. Fielding, R. Marks, S. Goldacker, J. Thaventhiran, MD Tarzi, M. Schlesier, U. Salzer, H. Eibel, K. Warnatz, J. Finke, B. Grimbacher, HH. Peter. 2011. Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiency. J Allergy Clin Immunol, 2011 Dec; 128 (6):1371-1374.e2. Epub 2011 Sep 17

M. Grünke, M. Ronneberger, A. Schnez, M.N. Witt, R.P. Laubender, M. Engelbrecht, C.E. Antoni, A. Kavanaugh, and H. Schulze-Koops. 2011. Use of the 28 joint count yields significantly higher concordance between different examiners than the 66/68 joint count. J Rheumatol, in press

M. Aringer, H. Burkhardt, G. R. Burmester, R. Fischer-Beetz, M. Fleck, W. Graninger, F. Hiepe, A. M. Jacobi, I. Kötter, H.-J. Lakomek, H.-M. Lorenz, G. Schett, M. Schneider, H. Schulze-Koops, J. S. Smolen, C. Specker, T. Stoll, H.-P. Tony, T. Witte, P. Villiger, R. Voll, and T. Dörner. 2011. Current state of evidence on “off label” therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria, and Switzerland – a consensus report. Lupus, in press

H.-D. Chang, T. Kamradt, and H. Schulze-Koops. 2011. [Th1, Th17 and Th1+Th17 cells]. Z Rheumatol, in press

M. Grünke. 2011. Können Biologika bei rheumatoider Arthritis nach Erreichen einer Remission abgesetzt werden? Contra. Dtsch Med Wochenschr 136:1675

C. Dechant, K. Krüger. 2011. Adulter Morbus Still, Aktuelle Diagnostik & Therapie. Dtsch Med. Wochenschr 136:1669

Mueller S, Weichert N, Stoecklein V, Hammitzsch A, Pascuito G, Krug C, Holzer M, Pfeiffer M, Siebeck M, Schmidmaier R: Evaluation of effectiveness of instruction and study habits in two consecutive clinical semesters of the medical curriculum munich (MeCuM) reveals the need for more time for self study and higher frequency of assessment. BMC Med. Educ. 2011 Aug 26; 11:62.

M. Czihal, F. Tatò, A. Rademacher, P. Kuhlencordt, H. Schulze-Koops and U. Hoffmann. 2011. Involvement of the femoropopliteal arteries in giant cell arteritis: a clinical and colour duplex sonography study. J Rheumatol, in press

H. Schulze-Koops and H.E. Blum. 2011. [Rheumatology today – a dynamic discipline for the patient’s good]. Dtsch Med Wochenschr 136:1651

R. Cron and H. Schulze-Koops. 2011. 1.5 Decades Later: Bearing Fruits from the ACR/EULAR Exchange Program. Pediatric Rheumatology 9:14, doi:10.1186/1546-0096-9-14

H.P. Tony, G. Burmester, H. Schulze-Koops, M. Grunke, J. Henes, I. Kötter, J. Haas, L. Unger, S. Lovric, M. Haubitz, R. Fischer-Betz, G. Chehab, A. Rubbert-Roth, C. Specker, J. Weinerth, J. Holle, U. Müller-Ladner, R. König, C. Fiehn, P. Burgwinkel, K. Budde, H. Sörensen, M. Meurer, M. Aringer, B. Kieseier, C. Erfurt-Berge, M. Sticherling, R. Veelken, U. Ziemann, F. Strutz, P. von Wussow, F.M. Meier, N. Hunzelmann, E. Schmidt, R. Bergner, A. Schwarting, R. Eming, M. Hertl, R. Stadler, M. Schwarz-Eywill, S. Wassenberg, M. Fleck, C. Metzler, U. Zettl, J. Westphal, S. Heitmann, A.L. Herzog, H. Wiendl, W. Jakob, E. Schmidt, K. Freivogel, T. Dörner; GRAID investigators. 2011. Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID). Arthritis Res Ther 13:R75

J. Leipe*, M. Schramm*, M. Baeuerle, C. Dechant, M. Grunke, M. Witt, A. Nigg, C. Reindl, H. Schulze-Koops, and Alla Skapenko. 2011. Interleukin-22 serum levels are associated with clinical outcome in rheumatoid arthritis. Ann Rheum Dis 70:1453-7

A. Cauli, D. Gladman, A. Mathieu, I. Olivieri, G. Porru, P. Tak, C. Sardu, I. Ujfalussy, R. Scarpa, A. Marchesoni, W. Taylor, A. Spadaro, J.L. Fernàndez-Sueiro, C. Salvarani, J. Kalden, E. Lubrano, C. Sueli, F. Desiati, J. A. Flynn, S. d’Angelo, A. Vacca, A. van Kuijk, M. G. Catanoso, M. Grunke, R. Peluso, W. J. Parsons, N. Ferrara, P. Contu, P. Helliwell and P. Mease for the GRAPPA 3PPsA study group, “Patient global assessment in psoriatic arthritis: a multicentre GRAPPA and OMERACT study”, J Rheumatol, in press

I. Prots, A. Skapenko, P.E. Lipsky, and H. Schulze-Koops. 2011. Analysis of the transcriptional program during the development of induced regulatory T cells. PLoS One, 6:e16913

L. Arnaud, B. Hervier, A. Néel, MA. Hamidou, JE. Kahn, B. Wechsler, G. Pérez-Pastor, B. Blomberg, JG. Fuzibet, F. Dubourguet, A. Marinho, C. Magnette, V. Noel, M. Pavic, J. Casper, AB. Beucher, N. Costedoat-Chalumeau, L. Aaron, J. Salvatierra, C. Graux, P. Cacoub, V. Delcey, C. Dechant, P. Bindi, C. Herbaut, G. Graziani, Z. Amoura, and J. Haroche. 2011. CNS involvement and treatment with interferon-alpha are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients. Blood 2011 Jan 14. [Epub ahead of print]

K. Thümmler, N. Häntzschel, A. Skapenko, H. Schulze-Koops und A. Picj. 2010. Surfactant-free poly(styrene-co-glycidyl methacrylate) polymeric particles with surface bound antibodies for activation and proliferation of human T cells., Bioconjug Chem 21:867-87

J. Leipe, M. Grunke, C. Dechant, C. Reindl, U. Kerzendorf, H. Schulze-Koops und A. Skapenko. 2010. Th17 cells in autoimmune arthritis. Arthritis Rheum 62:2876-85

A. Nigg and H. Schulze-Koops. 2010. [Disease course – scores for evaluation]. In: Langzeittherapie der rheumatoiden Arthritis, edited by H. P. Tony. Uni-Med Verlag, Bremen: Chapter 2, pp 19 – 28

M. Grunke, C. E. Antoni, A. Kavanaugh, V. Hildebrand, C. Dechant, G. Schett, B. Manger, M. Ronneberger, “Standardization of joint examination technique leads to a significant decrease in variability among different examiners”, J Rheumatol 37:860-4

S. G Mattyasovszky, A. Hofmann, C. Brochhausen, U. Ritz, S. Kuhn, J. Wollstädter, H. Schulze-Koops, L. P. Müller, B. Watzer, and P. M Rommens. 2010. The effect of the pro-inflammatory cytokine TNF-alpha on human joint capsule myofibroblasts, Arthritis Res Ther 12:R4

K. Thümmler, J. Leipe, A. Ramming, H. Schulze-Koops, and A. Skapenko. 2010. Immune regulation by peripheral Tregs induced upon homotypic T cell/T cell interactions, J Leukocyte Biol 88:1041-50

S. Mayer-Wagner, F. Wiendl, S. Schewe, M. Grünke, H. Schulze-Koops, P. Delhey, V. Jansson, and J. Hausdorf. 2010. [Quality of an interdisciplinary clinic in orthopedic rheumatology]. Z Rheumatol 69:749-54

M. Czihal, F. Tatò, S. Förster, A. Rademacher, H. Schulze-Koops, and Ulrich Hoffmann. 2010. Fever of unknown origin as initial manifestation of large vessel giant cell arteritis: diagnosis by colour-coded sonography and 18-FDG-PET. Clin Exp Rheumatol 28:549-52

H. Schulze-Koops and A. Skapenko. 2010. Control of autoimmune inflammation by TREG cells: a matter of time? Nat Rev Rheumatol, 6:620-1

M. Grünke*, H. Bastian*, H. Schulze-Koops†, and G.-R. Burmester†. 2010. [Novel biologics and oral drugs. What is in the pipeline?]. Z Rheumatol 69:626-32

C. Reindl, M. Grünke, and H. Schulze-Koops. 2010. [Rheumatoid arthritis – internal medicine aspects]. Therapiehandbuch, in press

C. Gebhardt, I. Kirchberger, G. Stucki, A. Cieza. 2010. Validation of the comprehensive ICF Core Set for rheumatoid arthritis: the perspective of physicians. J Rehabil Med 42:780-8

H. Mannell, A. Hammitzsch, R. Mettler, U. Pohl, F. Krötz. 2010. Suppression of DNA-PKcs enhances FGF-2 dependent human endothelial cell proliferation via negative regulation of Akt. Cell Signal 22:88-96

M. N. Witt, M. Ronneberger, A. Schnez, C. Reindl, R. P. Laubender, A. Kavanaugh, H. Schulze-Koops, M. Grunke, „Marked discrepancies in patient-reported tenderness and clinically detectable swelling in joints of the 66/68 joint count”, Ann Rheum Dis; 69 (Suppl3): 508

S. Steinbach, F. Proft, H. Schulze-Koops, F. Hundt, P. Heinrich, S. Schulz, M. Grunke, „Gustatory and olfactory function in rheumatoid arthritis”, Scand J Rheumatol 40:169-77

H. Schulze-Koops, M. Deeg, C. Runge, T. Volmer und J. G. Brecht. 2009. Gesundheitsökonomische Bewertung der Kombinationstherapie der rheumatoiden Arthritis mit Methotrexat und Etanercept auf der Basis der TEMPO-Studie, Z Rheumatol 68:836-841

A. P. Nigg und H. Schulze-Koops. 2009. Pharmakotherapie der rheumatoiden Arthritis auf Reisen. Rheumamedizin 6:70-78

A. Ramming, K. Thümmler, H. Schulze-Koops und A. Skapenko. 2009. Homotypic T cell/T cell interaction induces T cell activation, proliferation, and differentiation. Hum Immunol 70:873-881

A. Skapenko, I. Prots und H. Schulze-Koops. 2009. Prognostic factors in rheumatoid arthritis in the biologic era. Nature Rev Rheumatol 5:491-496

M. N. Witt, G. S. Braun, S. Ihrler, H. Schmid. 2009. Occurrence of HSV-1-induced pneumonitis in patients under standard immunosuppressive therapy for rheumatic, vasculitic, and connective tissue disease. BMC Pulm Med 9:22-31

M. N. Witt, B. Hartmann, H. Schmid. 2009 Pharmakotherapie des primären nephrotischen Syndroms des Erwachsenen. Internistische Praxis 49:465-696

M. N. Witt und H. Schulze-Koops. 2009. Prognostische Marker der rheumatoiden Arthritis. Rheumamedizin 6:10-16

J. Leipe, A. Skapenko und H. Schulze-Koops. 2009. Th17-Zellen – eine neue proinflammatorische T-Zell-Population und ihre Bedeutung für rheumatologische Autoimmunerkrankungen. Z Rheumatol 68:408-408

K. Thuemmler, A. Ramming, H. Schulze-Koops und A. Skapenko. 2009. Zelluläre Therapie von Autoimmunerkrankungen. Z Rheumatol 68:337-379

M. C. Mueller, E. Fleischmann, M. Grunke, S. Schewe und J. R. Bogner, T. Löscher. 2009. Relapsing cutaneous leishmaniasis in a patient with ankylosing spondylitis treated with infliximab. Am J Trop Med Hyg 81: 52-54

C. Reindl und H. Schulze-Koops. 2009. Gängige Immunsuppressiva und deren Wirkungsmechanismus – ein Überblick für den praktisch tätigen Arzt. Internistische Praxis 49, 147-159

M. Grunke, A. Schnez, M. Ronneberger, A. Kavanaugh, G. Schett, C. E. Antoni, H. Schulze-Koops, “Differences in the interrater agreement between the joints of the 68/66 and the 28 joint count”, Ann Rheum Dis, 68 (suppl III): 531

C. Gordon, D. Jayne, C. Pusey, D. Adu, Z. Amoura, M. Aringer, J. Ballerin, R. Cervera, J. Calvo-Alén, C. Chizzolini, J.-M. Dayer, A. Doria, F. Ferrario, J. Floege, L. Guillevin, M. Haubitz, F. Hiepe, F. Houssiau, P. Lesavre, L. Lightstone, P. L. Meroni, O. Meyer, B. Moulin, K. O’Reilly, M. Praga, H. Schulze-Koops, A. Sinico, K. Smith, A. Tincani, C. Vasconcelos, R. van Vollenhoeven, and G. Hughes. 2009. European consensus statement on the terminology used in the management of lupus glomerulonephritis. Lupus 18:257-63

T. G. Berger, H. Schulze-Koops, M. Schäfer, E. Müller, and M.B.Lutz. 2009. Immature and maturation-resistant human dendritic cells generated from bone marrow require two stimulations to induce T cell anergy in vitro. PLoS one 4:e6645

C. Dechant, and O. Sander. 2009. Kapillarmikroskopie. Arthritis & Rheuma 29: 179-185

M. N. Witt und H. Schulze-Koops. 2008. Prognostische Markers der rheumatoiden Arthritis. Der Bay Int 28:11-17

H. Schulze-Koops und P. E. Lipsky. 2008. T cell-targeted therapy for rheumatoid arthritis. In: Immune regulation and immunotherapy in autoimmune diseases, edited by J. Zhang. Springer, New York: Chapter 18, 425-437

C. Dechant und H. Schulze-Koops. 2008. Adult-onset Still’s disease. Akt Rheumatol 33:108-114A. P. Nigg, H. Schulze-Koops, S. Wirth, M. Weiss und J. R. Bogner. 2008. Tuberculous spondylitis. Infection 36:293-294

J. Schildmann, M. Grunke, J.R. Kalden und J. Vollmann. 2008. Information and participation in decision-making about treatment: a qualitative study of the perceptions and preferences of patients with rheumatoid arthritis. J Med Ethics 34:775-779

J. Rech, A. J. Hueber, S. Kallert, J. Leipe, J. R. Kalden, M. Beck, G. Schett und H. Schulze-Koops. 2008. Remission of demyelinating polyneuropathy with immunoadsorption, low dose corticosteroids and anti-CD20 monoclonal antibody. Ther Apher Dial 12:205-208

A. P. Nigg, J. R. Bogner, S. Thurau und H. Schulze-Koops. 2008. An uncommon cause of retinal vasculitis. Int J Adv Rheumatol 5:127-130

A. P. Nigg, J. Hausdorf und S. Schewe. 2008. Kapitel 4: Bewegungsapparat. Medizinische Gutachten (Dörfler, Eisenmenger, Lippert und Wandl, Hrsg.) Springer Berlin Heidelberg.

R. H. Straub, G. Pongratz, M. Cutolo, C. A. Wijbrandts, D. Baeten, M. Fleck, F. Atzeni, M. Grunke und J. R. Kalden. 2008. Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti–tumor necrosis factor therapy in rheumatoid arthritis. Arthritis Rheum 58:976-984

J. Stieglmaier, E. Bremer, C. Kellner, T. M. Liebig, B. ten Cate, M. Peipp, H. Schulze-Koops, M. Pfeiffer, H.J. Bühring, J. Greil, F. Oduncu, B. Emmerich, G. H. Fey, and W. Helfrich. 2008. Selective induction of apoptosis in leukemic B-lymphoid cells by a CD19-specific TRAIL fusion protein. Cancer Immunol Immunother 57:233-46

H. Schmid, M. N. Witt und H. Kellner. Reaktive Arthritiden. 2007. Internistische Praxis 47:79-88G.

S. Braun, M. N. Witt, V. Mayer, H. Schmid. 2007. Hypercalcemia caused by vitamin D3 analogs in psoriasis treatment. Int J Dermatol 46:1315-1317

A. P. Cope, H. Schulze-Koops und M. Aringer. 2007. The central role of T cells in rheumatoid arthritis. Clin Exp Rheumatol 25:S4-11

H. Schulze-Koops und J. R. Kalden. 2007. T cells – Overview – Update. In: Contemporary targeted therapies in rheumatology, edited by J. S. Smolen and P. E. Lipsky. Informa Healthcare, London: Chapter 1, pp 1 – 6R.

B. Mueller, A. Skapenko, J. Wendler, F. Schuch, J. R. Kalden und H. Schulze-Koops. 2007. MHC class II expression on myeloid cells inversely correlates with disease progression in early rheumatoid arthritis. Rheumatology46:931-933

M. Grunke. 2007. Systemischer Lupus Erythematodes. Der Bay Int 27 (5): 259

Ronneberger M, Antoni CE, Kavanaugh AF, Hildebrand V, Dechant C, Manger B, Grunke M, “Standardisation of joint examination technique leads to a significant decrease of  variability between different examiners and to increased specificity for affected joints”, Ann Rheum Dis 66 (suppl II): 262

J. Rech, F. Fuchs, S. Kallert, A. J. Hueber, C. Requadt, B. Manger, J. R. Kalden, K. Amann, R. Strauss, and H. Schulze-Koops. 2007. Plasmapheresis therapy in an elderly patient with rapidly progressive Henoch-Schonlein purpura with dissiminated organ involvement. Clin Rheumatol 26:112-114

J. Leipe, A. Hueber, S. Kallert, J. Rech, and H. Schulze-Koops. 2007. Autosplenectomy: Rare syndrom associated with autoimmunopathy. Ann Rheum Dis 66:566-567

H. Schulze-Koops. 2007. [Prognostic factors in rheumatoid arthritis]. In: Fortschritte der Klinischen Rheumatologie, edited by J. Wollenhaupt and H.-G. Pott, Preuss, Ratingen, pp 8-18

J. Auer, M. Blaess, H. Schulze-Koops, S. Russwurm, T. Nagel, J. R. Kalden, M. Roellinghoff, and H. U. Beuscher. 2007. Expression and regulation of CCL18 in synovial fluid neutrophiles of patients with rheuamtoid arthritis. Arthritis Res Ther 9:R94

A. Skapenko and H. Schulze-Koops. 2007. Analysis of Th1/Th2 T cell subsets. Methods Mol Med 136:87-96

H. Schulze-Koops and J. R. Kalden. 2007. T cells – Overview – Update. In: Contemporary targeted therapies in rheumatology, edited by J. S. Smolen and P. E. Lipsky. Informa Healthcare, London: Chapter 1, pp 1 - 6

A. P. Cope, H. Schulze-Koops, and M. Aringer. 2007. The central role of T cells in rheumatoid arthritis. Clin Exp Rheumatol 25:S4-11

M. M. Zaiss, R. Axmann, J. Zwerina, K. Polzer, E. Gückel, A. Skapenko, H. Schulze-Koops, N. Horwood, A. Cope, and G. Schett. 2007. Regulatory T cells suppress osteoclast formation – a new link between the immune system and bone. Arthritis Rheum 56:4104-12

H. Horner, C. Frank, C. Dechant, R. Repp, M. Glennie, M. Herrmann, and B. Stockmeyer. 2007. Intimate cell conjugate formation and exchange of membrane lipids precede apoptosis induction in target cells during antibody-dependent, granulocyte-mediated cytotoxicity. J Immunol 179: 337-45